Lynda Szczech Email

VP Clinical Development . FibroGen

Current Roles

Employees:
527
Revenue:
$283.8M
About
FibroGen has developed the only commercially viable method known to produce human collagen and human gelatin in recombinant systems. FibroGen will exploit this technology by becoming both a bulk product supplier for the pharmaceutical and medical device industries as well as a developer and commercializer of injectable products, wound management products, and gelatin stabilizers. FibroGen's corporate collaborations include a partnership with Taisho Pharmaceutical Company of Japan to discover and develop human monoclonal antibody therapeutics for renal fibrosis and chronic transplant rejection.
FibroGen Address
409 Illinois Street
San Francisco, CA
United States
FibroGen Email

Past Companies

Self-employedNephrology Clinical Trial and Medical Affairs Consulting
NaphCare, Inc.Nephrologist in Private Practice
FibroGen, Inc.Vice President Clinical Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.